Hydroxyurea to Treat Beta-Thalassemia (Cooley’s Anemia)
Learn more about:
Related Access Program
Related Clinical Trial
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia
Lucky Iron Fish Home Fortification of Iron
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders
Hydroxyurea to Treat Beta-Thalassemia (Cooley’s Anemia)
Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous